News Archive - Biognosys

Newsroom

Filter By
January 2023
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics, expected to benefi [...]

Read more
December 2022
Biognosys Launches New Version of Spectronaut® at HUPO International Proteomics Congress

Spectronaut 17 features directDIA+™, the best-performing library-free workflow for DIA proteomics available on the market.

Read more
October 2022
Biognosys in Publications 2022

A growing number of scientific publications have been using Biognosys' technology and tools in the first half of 2022.

Read more
October 2022
Biognosys to Present at ALDA Fall 2022 Senior Executive Conference on Trends in Pharma Discovery & Manufacturing

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that they are participating in the ALDA (Analytical, Life Science &a [...]

Read more
September 2022
Biognosys Expands Its Global Presence with a US Office in Biopharma Hub Cambridge, Massachusetts

The expansion is part of the company’s growth strategy for North America and will foster collaboration with life science companies and academia. An inauguration event will take p [...]

Read more
September 2022
Biognosys to Participate in Capital One Spatial Biology & Proteomics Healthcare Disruptors Summit

Biognosys announced today that they are participating in the upcoming Capital One Spatial Biology & Proteomics Healthcare Disruptors Summit, taking place virtually on Wednesday, Se [...]

Read more
Load More

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Access

Contact

    Close banner

    New: Spectronaut® 17

    A Groundbreaking Increase in Identifications

    New: Spectronaut® 17

    A Groundbreaking Increase in Identifications

    Learn More